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mutations in the SHR that do not impact on the molecular weight of the native
protein, but may affect its post-translational modification (PTM). This notion
is supported by additional data, which suggest an alteration in 
 
O
 
-linked -N-
acetylglucosamination. 
 
Conclusion:
 
 Our results emphasize the role of the SHR Cd36 gene defect
as the factor underlying its cardiac restricted LCFA utilization. The functional
impact of this gene defect includes alterations in CD36 protein level and sus-
ceptibility to PTM.
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Introduction:
 
 Thrombi in contact with non re-endothelialized stent struts
associated with drug-eluting stent (DES) thrombosis. Hence, detection of
thrombi in DES could help to evaluate the risk of DES thrombosis. Annexin
V radio-labelled with 99mTechnetium (99mTc) is a radio-tracer with a high
affinity for activated platelets.
 
Objectives:
 
 Our objectives were: 1) to develop an animal model of non-
occlusive thrombosis of stents, 2) to evaluate the ability of annexin V 99mTc
for the detection of in-stent thrombi using scintigraphy. 
 
Methods:
 
 Right carotid arteries of NZW rabbits (n = 14) fed a high cho-
lesterol diet were implanted with overlapping DES (n = 7) or bare-metal
stents (BMS; n = 7). Four weeks after stent implantation, rabbits underwent
a first scintigraphy 3 hours after injection of 200 MBq of radio-labelled
annexin V 99mTc. At the end of the first scintigraphy, a suture was placed
surgically proximal to the stented carotid arteries in order to induce a
thrombus-prone flow limiting stenosis. Four days later, a second scintig-
raphy was performed. After the second scintigraphy, stents were excised,
imaged ex vivo and then fixed for histological examination and scanning
electron microscopy (SEM). 
 
Results:
 
 Activities measured in vivo in the stented carotid arteries after injec-
tion of annexin V 99mTc were higher on the second scintigraphy after creation
of a surgical stenosis as compared to the first scintigraphy (0.24 vs. 0.15 counts/
pixel/ MBq, respectively; p<0.05). On the second scintigraphy, activities were
higher in DES vs. BMS (0.26 vs. 0.19 counts/pixel/ MBq, respectively;
p < 0.005). High activities measured in stents in vivo were associated with the
detection of thrombi on corresponding histological sections and SEM.
 
Conclusions:
 
 In this work, we developed a rabbit model of non-occlusive
thrombosis of stents in carotid arteries. In this model, in-stent thrombi could
be detected using annexin V 99mTc scintigraphy.
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Aim: Glutamine is the most abundant amino acid in the plasma, and has
been shown to exert cardioprotective effects. However, the underlying mech-
anisms remained unclear, but may include an anaplerotic effect via its meta-
bolic conversion to citric acid cycle (CAC) intermediates or activation of the
hexosamine biosynthetic pathway (HBP). 
Methods: To assess the potential roles of these mechanisms, we evaluated
the metabolic effects of a physiologically relevant concentration of glutamine
(0.5mM) in isolated working rat hearts perfused with 13C-labeled substrates
with or without 20 M azaserine (an HBP inhibitor) and under restricted supply
of carbohydrates (CHO, i.e. without pyruvate/insulin). 
Results: When perfused with a mixture of CHOs, a fatty acid oleate and
insulin (controls), the addition of glutamine had no effect on functional
parameters except for a 17% (p<0.05) decrease in relaxation. However it
resulted in an increase in the percent contribution of 13C-oleate to acetyl-
CoA production (51%) and triglyceride formation (2.8 folds). This was
accompanied by a significant reduction (p>0.05) tissue levels of the CAC
intermediates (in nmol/gww): citrate: 260±10 vs. 222±6 and malate 128±5
vs. 103±3 . Inhibition of HBP with azaserine restored oleate oxidation and
tissue CAC levels, but not triglyceride formation. When perfused under
restricted supply of CHOs, hearts displayed significantly decreased cardiac
output (65%), a greater percent contribution of glucose to pyruvate forma-
tion (60%), and lower tissue citrate and malate levels (45%). Addition of
glutamine restored cardiac output and glucose contribution to pyruvate for-
mation but not tissue CAC levels. 
Conclusion: Collectively, these results demonstrate the capacity of
glutamine to modulate energy substrate selection and function in the perfused
heart. Furthermore, the potential mechanisms underlying these effects appear
to be mediated via the HBP rather than anaplerosis.
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Background: Aspirin resistance has been widely reported but the under-
lying mechanisms remain unclear. Previous studies have suggested a relation-
ship between accelerated platelet turn-over and aspirin resistance in patients
with coronary artery disease. The purpose of this study was to determine
whether aspirin resistance could be linked to accelerated platetet turn-over.
Methods: We performed a prospective monocentric study including 50
consecutive patients with stable coronary artery disease treated by aspirin (75
to 250 mg/day) without any other antiaggregant treatment. Aspirin resistance
was characterized 24 hours after aspirin intake by light transmission aggrego-
metry using 0.5 mg/mL arachidonic acid. Aspirin resistance was defined as
>20% residual agregation. Platelet turn-over was estimated at the same time
by measurement of mean platelet volume, % of reticulated platelets, serum P-
selectin, platelet P-selectin and serum thrombopoietin.
Results: Among 50 patients (70±11 y.o. mean±1,5, 76% male, 52% type 2
diabetes mellitus, 16% active smokers), 18 (36%) were identified as aspirin
resistants. Table 1 shows the mean value of markers currently linked to
platelet turn-over depending on the presence of aspirin resistance. Serum
thrombopoietin was significantly increased in patients with aspirin resistance
compared to patients with no aspirin resistance. No statistical difference was
demonstrated for mean platelet volume, reticulated platelets, platelet P-selectin
and serum P-selectin. Serum thrombopoietin values were not correlated with
other platelet turn-over parameters. There was no significant correlation
between serum thrombopoietin and inflammatory markers.
Conclusion: Serum thrombopoietin is associated with aspirin resistance,
but no other parameters currently linked to platelet turn-over. Further studies
are needed to determine whether serum thrombopoietin can predict aspirin
resistance in a larger cohort.
© Elsevier Masson SAS. All rights reserved.
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Introduction: Recent finding suggest that inflammation plays a role in athero-
sclerosis and its acute complications. Several known mechanisms may play at least
a partial role in this process. One of the most likely mechanisms involves
lipopolysaccharide (LPS) and its receptor, CD14. The C(-260)T single nucleotide
polymorphism in the promoter region of the CD14 receptor gene has been reported
to be associated with a higher risk of MI. Others studies, however, have not cor-
roborated these findings. Considering the contradictory results, the aim of the
present study was to investigate the possible association between the CD14 C(-
260)T polymorphism and the risk of MI in the Tunisian population.
Material and Methods: A total of 333 Tunisian patients with MI and 345 healthy
controls were included in the study. Genotyping was performed by polymerase
chain reaction-restriction fragment length polymorphism (PCR-RFLP) analysis.
Results: The frequency of TT homozygous genotype for the CD14 C(-
260)T polymorphism was 24.9% in MI patients and 24.0% in the control
group. However, the genotype distribution and allele frequencies were not sig-
nificantly different between MI and controls subjects. Moreover, the odds ratio
for MI associated with the T allele failed to reach statistical significance
(OR=1.08; 95% CI: 0.86 - 1.34; P=NS).
Conclusion: These results do not support the hypothesis that the C-260T poly-
morphism of CD14 gene contributes to the genetic susceptibility to MI in the
Tunisian population studied.
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Introduction: Arginase I (ARG I) is the final enzyme of the urea cycle that
converts L-arginine to urea and ornithine. Emerging evidence have identified
ARG I as a critical regulator for nitric oxide (NO) production via nitric oxide
synthase (NOS).
Therefore upregulation of ARG I inhibit NOS-mediated NO and may con-
tribute to endothelial dysfunction. In addition, pathophysiological role of ARG
I on vascular disease have been extensively documented, and some recent
studies support a role for ARG I in the development and complications of cor-
onary artery disease (CAD). The aim of the present study is to investigate the
possible association between rs 2781666 G/T polymorphism of ARG I gene
and myocardial infarction (MI) in the Tunisian population.
Methods: In a case-control study, a total of 321 patients with MI and
436 controls were included. The rs 2781666 G/T polymorphism of ARG I was
determined by PCR-RFLP analysis.
Results: Patients with MI had significantly higher frequency of TT genotype com-
pared to controls (10.3 % vs 6.7 %; OR (95 % CI), 2.05 (1.19 - 3.52), p=0.009).
The MI patients showed higher frequency of T allele compared to the controls
(0.32 vs 0.23, OR (95 % CI), 1.58(1.25 - 2.00), p<0.001). The association between
rs 2781666 G/T polymorphism of ARG I gene and MI was no longer significant
after adjustment for other well established risk factors. 
Conclusion: Our results revealed a significant but not independent associ-
ation between rs2781666 G/T polymorphism of ARG I gene and (MI) in the
Tunisian population.
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Objective: Resistin is a polypeptide (hormone) that is specifically secreted
from adipocytes. It plays an important role in communication between adi-
posity and insulin resistance and it has been linked to the pathogenesis of ath-
erosclerosis. Recently, -420C>G, a variant located in the promoter region of
the resistin gene (RETN) (rs1862513) was identified. The aim of this study
was to investigate the association between this polymorphism and the risk of
myocardial infarction (MI) in the Tunisian population.
Design and methods: A total of 787 unrelated male Tunisian subjects
including 455 healthy controls and 332 patients who had survived a first MI
were prospectively recruited. Standard definitions and criteria for MI diagnosis
were employed. Blood samples were obtained after an overnight fast. Serum
glucose, TC and TG were measured by standardized enzymatic methods using
commercial kits (Roche Diagnostics, Mannheim, Germany) on a Hitachi
912 analyzer. Genomic DNA was extracted from peripheral blood leukocytes
according to standard methods. -420C>G polymorphism genotypes were deter-
mined by polymerase chain reaction followed by restriction analysis with
5 units of BbsI. Digested products were separated on 2.5% agarose gel with
ethidium bromide staining.
Results: The frequencies of RETN -420G allele in MI group, and control
group were 0.45 and 0.41, which are met with the Hardy-Weinberg equilibrium.
Compared with controls, there was no significant differences in distribution of
genotypes and allele frequencies of -420 C>G polymorphic site in MI patients and
controls. In addition, there was no significant difference between the genotypes
with lipid profiles. 
Conclusion: Our data suggest that the RETN -420C>G polymorphism is
not associated with an increased risk of MI in a Tunisian population.  
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Aspirin sensitive Aspirin resistant p
Platelet volume (fl) 8.78±0.26 8.82±0.30 0.92
Reticulated platelet (%) 8.4±0.52 8.6±0.76 0.82
Serup P selectin (ng/ml) 42.6±4.29 42.9±4.75 0.97
Platelet P selectin (%) 11.1±1.0 9.5±1.5 0.35
Serum thrombopoietin (pg/ml) 130.6±11.3 319.9±97.8 0.01
